These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8171041)

  • 21. Na
    Bejček J; Spiwok V; Kmoníčková E; Rimpelová S
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33800655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the Na
    Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
    J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site.
    Dostanic-Larson I; Lorenz JN; Van Huysse JW; Neumann JC; Moseley AE; Lingrel JB
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R524-8. PubMed ID: 16467499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Na,K-ATPase: structure-function studies.
    Lingrel JB; Van Huysse J; O'Brien W; Jewell-Motz E; Schultheis P
    Ren Physiol Biochem; 1994; 17(3-4):198-200. PubMed ID: 7518958
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac glycoside binding to the Na/K-ATPase in the intact myocardial cell: electrophysiological measurement of chemical kinetics.
    Daut J; Rüdel R
    J Mol Cell Cardiol; 1981 Aug; 13(8):777-82. PubMed ID: 6267307
    [No Abstract]   [Full Text] [Related]  

  • 26. Endogenous cardiac glycosides, a new class of steroid hormones.
    Schoner W
    Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a model cardiac glycoside receptor: comparisons with Na+,K+-ATPase.
    Kasturi R; Yuan J; McLean LR; Margolies MN; Ball WJ
    Biochemistry; 1998 May; 37(19):6658-66. PubMed ID: 9578549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoschisin and Cardiac Glycoside Crosstalk at the Retinal Na/K-ATPase.
    Schmid V; Plössl K; Schmid C; Bernklau S; Weber BHF; Friedrich U
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):1. PubMed ID: 32392309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase.
    Lingrel JB
    Annu Rev Physiol; 2010; 72():395-412. PubMed ID: 20148682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
    Schwalb H; Dickstein Y; Heller M
    Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
    [No Abstract]   [Full Text] [Related]  

  • 31. [Na+ + K+] Mg2+-ATPase of muscle plasma membranes in Duchenne muscular dystrophy.
    Niebrój-Dobosz I
    Neurology; 1981 Mar; 31(3):331-4. PubMed ID: 6259558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncoupling of ATP binding to Na+,K+-ATPase from its stimulation of ouabain binding: studies of the inhibition of Na+,K+-ATPase by a monoclonal antibody.
    Ball WJ
    Biochemistry; 1986 Nov; 25(22):7155-62. PubMed ID: 3026448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of ouabagenin and (Na+ + K+)-ATPase in the presence of Na+, Mg2+, and ATP.
    Yoda A; Yoda S
    Mol Pharmacol; 1981 Jan; 19(1):62-7. PubMed ID: 6259513
    [No Abstract]   [Full Text] [Related]  

  • 34. Ouabain, endogenous ouabain and ouabain-like factors: The Na
    Blaustein MP; Hamlyn JM
    Cell Calcium; 2020 Mar; 86():102159. PubMed ID: 31986323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na,K-ATPase from placenta of women with pregnancy-induced hypertension exhibits an increased affinity for cardiac glycosides.
    Amler E; Cester N; Magnanelli R; Mazzanti L; Kotyk A; Romanini C
    Physiol Res; 1994; 43(1):33-6. PubMed ID: 8054335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
    Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
    Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nature of the transport ATPase-digitalis complex. II. Some species differences and ouabain "exchange" characteristics.
    Allen JC; Harris RA; Schwartz A
    J Mol Cell Cardiol; 1971 Dec; 3(3):297-300. PubMed ID: 4378066
    [No Abstract]   [Full Text] [Related]  

  • 40. The Janus face of ouabain in Na
    Kinoshita PF; Orellana AMM; Nakao VW; de Souza Port's NM; Quintas LEM; Kawamoto EM; Scavone C
    Br J Pharmacol; 2022 Apr; 179(8):1512-1524. PubMed ID: 33644859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.